MeiraGTx Holdings is a clinical-stage gene therapy company focused on developing transformative treatments for patients living with serious diseases. With a cutting-edge technology platform and a diverse pipeline, the company aims to revolutionize the field of gene therapy and improve the lives of patients worldwide.
